Leonard Green & Partners Leads Recapitalization of WCG with Arsenal and Novo Holdings

November 14, 2019

An investor group led by Leonard Green & Partners, in partnership with Arsenal Capital Partners and Novo Holdings A/S, has agreed to recapitalize WCG to provide resources to accelerate growth and expand capabilities in clinical trial optimization. Financial terms were not disclosed; the transaction was announced in November 2019 and expected to close in the first quarter of 2020.

Targets
WCG
Location
North Carolina, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.